CCM
Cohen Capital Management’s Bio-Rad Laboratories Class A BIO Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | – | Sell |
-660
| Closed | -$217K | – | 153 |
|
2024
Q4 | $217K | Hold |
660
| – | – | 0.04% | 146 |
|
2024
Q3 | $221K | Buy |
+660
| New | +$221K | 0.04% | 145 |
|
2024
Q2 | – | Sell |
-660
| Closed | -$228K | – | 145 |
|
2024
Q1 | $228K | Hold |
660
| – | – | 0.04% | 132 |
|
2023
Q4 | $213K | Hold |
660
| – | – | 0.04% | 132 |
|
2023
Q3 | $237K | Hold |
660
| – | – | 0.05% | 125 |
|
2023
Q2 | $250K | Hold |
660
| – | – | 0.05% | 126 |
|
2023
Q1 | $316K | Hold |
660
| – | – | 0.06% | 122 |
|
2022
Q4 | $278K | Sell |
660
-75
| -10% | -$31.5K | 0.06% | 127 |
|
2022
Q3 | $307K | Hold |
735
| – | – | 0.07% | 126 |
|
2022
Q2 | $364K | Hold |
735
| – | – | 0.07% | 125 |
|
2022
Q1 | $414K | Hold |
735
| – | – | 0.07% | 125 |
|
2021
Q4 | $555K | Sell |
735
-15
| -2% | -$11.3K | 0.09% | 115 |
|
2021
Q3 | $559K | Hold |
750
| – | – | 0.1% | 115 |
|
2021
Q2 | $483K | Hold |
750
| – | – | 0.08% | 118 |
|
2021
Q1 | $428K | Hold |
750
| – | – | 0.08% | 118 |
|
2020
Q4 | $437K | Hold |
750
| – | – | 0.09% | 118 |
|
2020
Q3 | $387K | Sell |
750
-100
| -12% | -$51.6K | 0.09% | 116 |
|
2020
Q2 | $384K | Hold |
850
| – | – | 0.09% | 112 |
|
2020
Q1 | $298K | Hold |
850
| – | – | 0.09% | 108 |
|
2019
Q4 | $315K | Sell |
850
-50
| -6% | -$18.5K | 0.07% | 120 |
|
2019
Q3 | $299K | Hold |
900
| – | – | 0.07% | 122 |
|
2019
Q2 | $281K | Hold |
900
| – | – | 0.07% | 121 |
|
2019
Q1 | $275K | Hold |
900
| – | – | 0.07% | 118 |
|
2018
Q4 | $209K | Hold |
900
| – | – | 0.06% | 122 |
|
2018
Q3 | $282K | Hold |
900
| – | – | 0.06% | 125 |
|
2018
Q2 | $260K | Hold |
900
| – | – | 0.06% | 129 |
|
2018
Q1 | $228K | Hold |
900
| – | – | 0.05% | 131 |
|
2017
Q4 | $215K | Buy |
+900
| New | +$215K | 0.05% | 128 |
|
2017
Q3 | – | Sell |
-900
| Closed | -$204K | – | 138 |
|
2017
Q2 | $204K | Hold |
900
| – | – | 0.05% | 128 |
|
2017
Q1 | $179K | Buy |
+900
| New | +$179K | 0.05% | 128 |
|